Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.50 |
| ▸ | TSHR | P16473 | 4/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | GPR35 | Q9HC97 | 2/20 | 0.38 |
| ▸ | HTR2A | P28223 | 2/20 | 0.38 |
| ▸ | HTR2C | P28335 | 2/20 | 0.38 |
| ▸ | HTR2B | P41595 | 2/20 | 0.38 |
| ▸ | VCAM1 | P19320 | 3/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.37 |
| ▸ | TXNRD1 | Q16881 | 1/20 | 0.37 |
| ▸ | TXNRD3 | Q86VQ6 | 1/20 | 0.37 |
| ▸ | TXNRD2 | Q9NNW7 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11049111 | 0.82 | TSHR (0.41) | TDP1TSHRMAPK1GPR35VCAM1 | |
| SCHEMBL13836217 | 0.80 | TDP1 (0.50) | TDP1TSHRMAPK1GPR35ALDH1A1 | |
| SCHEMBL28123479 | 0.80 | TDP1 (0.47) | TDP1TSHRMAPK1GPR35HTR2A | |
| SCHEMBL27670471 | 0.80 | TDP1 (0.41) | TDP1TSHRMAPK1VCAM1ALDH1A1 | |
| SCHEMBL28002943 | 0.76 | TDP1 (0.43) | TDP1TSHRMAPK1GPR35HTR2A | |
| SCHEMBL16974731 | 0.76 | TDP1 (0.41) | TDP1TSHRMAPK1ALDH1A1HPGD | |
| SCHEMBL28003241 | 0.76 | ALDH1A1 (0.37) | TDP1TSHRMAPK1GPR35VCAM1 | |
| SCHEMBL1179475 | 0.75 | TDP1 (0.45) | TDP1TSHRMAPK1GPR35ALDH1A1 | |
| SCHEMBL9342102 | 0.74 | ALDH1A1 (0.44) | TDP1TSHRMAPK1VCAM1ALDH1A1 | |
| SCHEMBL8012114 | 0.74 | TDP1 (0.39) | TDP1TSHRMAPK1VCAM1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0296673-B1 | Thiazole derivatives | SHELL INT RESEARCH (NL) | 1994-03-09 | — | — | EP | claimed |
| US-4877802-A | FUNGICIDES | SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) | 1989-10-31 | — | — | US | claimed |
| EP-0296673-A1 | Thiazole derivatives | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1988-12-28 | — | — | EP | claimed |
| US-20150237857-A1 | ANTIBACTERIAL INHIBITORS | MCMASTER UNIVERSITY (CA) | 2015-08-27 | — | — | US | disclosed |
| EP-2882430-A1 | ANTIBACTERIAL INHIBITORS | McMaster University (CA) | 2015-06-17 | — | — | EP | disclosed |
| WO-2014022923-A1 | ANTIBACTERIAL INHIBITORS | MCMASTER UNIVERSITY (CA) | 2014-02-13 | — | — | WO | disclosed |
| EP-1345942-B9 | PYRAZINOQUINOXALINE DERIVATIVES AS SEROTONIN AGONISTS AND ANTAGONISTS | BRISTOL MYERS SQUIBB PHARMA CO (US) | 2006-11-15 | — | — | EP | disclosed |
| EP-1345942-B1 | PYRAZINOQUINOXALINE DERIVATIVES AS SEROTONIN AGONISTS AND ANTAGONISTS | BRISTOL MYERS SQUIBB PHARMA CO (US) | 2006-03-01 | — | — | EP | disclosed |
| US-6638934-B2 | 2,3,4,4a,5,6-hexahydro-1H-pyrazino(1,2-a)quinoxaline derivatives; treating depression, schizophrenia; (5-hydroxytryptamine=5HT) 5HT2a antagonist or a 5HT2c agonist | BRISTOL-MYERS SQUIBB PHARMA COMPANY | 2003-10-28 | — | — | US | disclosed |
| EP-1345942-A2 | PYRAZINOQUINOXALINE DERIVATIVES AS SEROTONIN AGONISTS AND ANTAGONISTS | Bristol-Myers Squibb Pharma Company (US) | 2003-09-24 | — | — | EP | disclosed |
| US-20020177596-A1 | Substituted pyrazinoquinoxaline derivatives as serotonin receptor agonist and antagonists ligands | BRISTOL-MYERS SQUIBB PHARMA COMPANY | 2002-11-28 | — | — | US | disclosed |
| WO-2002059127-A2 | PYRAZINOQUINOXALINE DERIVATIVES AS SEROTONIN AGONISTS AND ANTAGONISTS | BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) | 2002-08-01 | — | — | WO | disclosed |
| EP-0296673-B1 | Thiazole derivatives | SHELL INT RESEARCH (NL) | 1994-03-09 | — | — | EP | disclosed |
| US-4877802-A | FUNGICIDES | SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) | 1989-10-31 | — | — | US | disclosed |
| EP-0296673-A1 | Thiazole derivatives | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1988-12-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020177596-A1 | Substituted pyrazinoquinoxaline derivatives as serotonin receptor agonist and antagonists ligands | HTR1A, HTR5A, HTR1D | TDP1 4464/4885TSHR 254/4885MAPK1 1094/4885 |
| US-20150237857-A1 | ANTIBACTERIAL INHIBITORS | MRPL21, Q6ZSR9, SPOUT1 | TDP1 3742/4885TSHR 4204/4885MAPK1 711/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.